{{Rsnum
|rsid=7759
|Gene=DPAGT1
|Chromosome=11
|position=119096581
|Orientation=plus
|GMAF=0.3356
|Gene_s=DPAGT1,H2AFX
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 31.0 | 54.0 | 15.0
| HCB | 29.4 | 39.7 | 30.9
| JPT | 21.2 | 48.7 | 30.1
| YRI | 85.0 | 13.6 | 1.4
| ASW | 77.2 | 21.1 | 1.8
| CHB | 29.4 | 39.7 | 30.9
| CHD | 30.3 | 45.9 | 23.9
| GIH | 68.3 | 26.7 | 5.0
| LWK | 76.4 | 23.6 | 0.0
| MEX | 46.6 | 48.3 | 5.2
| MKK | 63.5 | 32.1 | 4.5
| TSI | 33.3 | 52.0 | 14.7
| HapMapRevision=28
}}{{PMID Auto
|PMID=24069324
|Title=Sex- and Subtype-Specific Analysis of H2AFX Polymorphisms in Non-Hodgkin Lymphoma
|OA=1
}}

{{PMID Auto
|PMID=17851762
|Title=Genetic variants in the H2AFX promoter region are associated with risk of sporadic breast cancer in non-Hispanic white women aged <or=55 years.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}